The kidney is resistant to chronic hypoglycaemia in late-gestation fetal sheep

Can J Physiol Pharmacol. 2007 Jun;85(6):597-605. doi: 10.1139/y07-047.

Abstract

We imposed a sustained reduction in glucose supply to late-gestation fetal sheep to see whether the reduction in glucose and insulin levels affected renal growth, renin expression and synthesis, and renal function. Maternal glucose concentrations were lowered to 1.7-1.9 mmol/L for 12-13 days by i.v. insulin infusion (n = 9, 121 days gestation, term = 150 days). Control ewes (n = 7) received vehicle. Maternal and fetal glucose concentrations were 40% and 31% lower than in controls (p < 0.001), respectively. Fetal plasma insulin levels fell 36% +/- 7% by day 7 (p < 0.05); IGF-I levels were unchanged. Arterial PO2 and pH increased and PCO2 fell (p < 0.05). Renal function was largely unaffected. Longitudinal growth was 28% slower and spleen weights were 36% smaller (p < 0.05); body and kidney weights were not affected. Renal renin levels and renin, angiotensinogen, and angiotensin receptor mRNA levels were similar to those of controls. Plasma renin levels increased from 2.1 +/- 0.6 to 7.6 +/- 2.8 ng angiotensin I.mL-1.h-1 (p = 0.01). Thus reductions in fetal glucose and insulin levels in late gestation that were sufficient to retard skeletal growth had no effect on kidney growth or function or the renal renin-angiotensin system, possibly because IGF-I levels were not reduced. There was, however, increased activity of the circulating renin-angiotensin system similar to that seen during insulin-induced hypoglycaemia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blood Glucose / analysis
  • Carbon Dioxide / blood
  • Chronic Disease
  • Female
  • Fetal Development / drug effects
  • Gestational Age
  • Heart Rate, Fetal / drug effects
  • Hydrocortisone / blood
  • Hypoglycemia / blood
  • Hypoglycemia / chemically induced
  • Hypoglycemia / physiopathology*
  • Hypoglycemic Agents / administration & dosage
  • Hypoglycemic Agents / toxicity
  • Infusions, Intravenous
  • Insulin / administration & dosage*
  • Insulin / toxicity
  • Insulin-Like Growth Factor Binding Proteins / metabolism
  • Kidney / drug effects*
  • Kidney / embryology
  • Kidney / metabolism
  • Kidney Function Tests
  • Organ Size / drug effects
  • Oxygen / blood
  • Potassium / metabolism
  • Pregnancy
  • Renin-Angiotensin System / drug effects
  • Sheep
  • Somatomedins / metabolism

Substances

  • Blood Glucose
  • Hypoglycemic Agents
  • Insulin
  • Insulin-Like Growth Factor Binding Proteins
  • Somatomedins
  • Carbon Dioxide
  • Potassium
  • Oxygen
  • Hydrocortisone